Ben Towne Center for Childhood Cancer Research

The Ben Towne Center’s mission is to translate scientific discoveries into innovative therapies that cure childhood cancer with minimal side effects and improve survivors’ quality of life.

Our Vision

We are spearheading treatments that use the immune system to eliminate cancer, without chemotherapy or radiation. Our goal is to render today’s therapies obsolete until treating childhood cancer is no different than treating an everyday virus.

Accelerating Progress Toward Cures

  • Goal: Cure Neuroblastoma

    Dr. Julie Park is leading one of the world’s first clinical studies of immunotherapy for neuroblastoma – the deadliest childhood cancer.

  • We Need Your Help

    You can help bring an end to childhood cancer all over the world, by supporting our Strong Against Cancer fundraising initiative.

Participate in Research

Our researchers have started the first round of clinical trials exploring a potential cure.

Help us answer questions about childhood health and illness, and help other children in the future. Learn more.


Developing groundbreaking cancer treatments takes more than just the right ideas. It also takes the right people.

Please visit Seattle Children’s careers page to learn about current openings.

For information about potential opportunities in the Ben Towne Center, email us.

Latest News

10 takeaways from the ASH Annual Meeting and Exposition01.06.17 – Healio/HemOnc Today The ASH Annual Meeting and Exposition featured the latest breakthroughs in treatment – including advances in immunotherapy and gene therapy – as well as advances in prevention and diagnosis of benign and malignant hematologic conditions. Dr. Rebecca Gardner of Seattle Children’s Hospital spoke with HemOnc Today about a study that evaluated an early intervention against cytokine release syndrome among patients with pre-B ALL who underwent anti-CD19 CAR T-cell therapy.

Bear Creek promotes school spirit and the fight against childhood cancer01.30.17PRLog In its third consecutive year, The Bear Creek School supported Strong Against Cancer to promote school spirit and engage the school population for a worthy cause. Throughout the week students sold purple capes and other purple spirit gear with proceeds benefiting Strong Against Cancer. The students raised $4,784.43 for the cause. During the week of Jan. 23, Upper School students heard from researchers at Seattle Children's Ben Towne Center for Childhood Cancer Research at their Monday morning assembly.

Immunotherapy trial for relapsed leukemia shows 93% remission rate 6.2.16 – Seattle Children’s Press Release Thirty-nine of 42 pediatric patients with acute lymphoblastic leukemia achieved complete remission in a Phase 1 clinical trial at Seattle Children’s. The trial uses genetically reprogrammed T cells to find and kill leukemia cells. Patients in the trial had less than a 20% chance of survival with current treatments.